301 related articles for article (PubMed ID: 25960762)
1. The missing pieces of the HCV entry puzzle.
Ogden SC; Tang H
Future Virol; 2015; 10(4):415-428. PubMed ID: 25960762
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of HCV entry into host cells.
Douam F; Lavillette D; Cosset FL
Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents.
Poumbourios P; Drummer HE
Antivir Chem Chemother; 2007; 18(4):169-89. PubMed ID: 17907376
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus entry: an intriguing challenge for drug discovery.
Meanwell NA
Curr Opin Investig Drugs; 2006 Aug; 7(8):727-32. PubMed ID: 16955684
[TBL] [Abstract][Full Text] [Related]
5. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
Blaising J; Pécheur EI
Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
Perrault M; Pécheur EI
Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
[TBL] [Abstract][Full Text] [Related]
8. Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets.
Crema A; Ponzetto A; Clementi M; Carloni G
Curr Drug Targets; 2015; 16(7):757-70. PubMed ID: 25694122
[TBL] [Abstract][Full Text] [Related]
9. Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes.
Belouzard S; Danneels A; Fénéant L; Séron K; Rouillé Y; Dubuisson J
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659476
[TBL] [Abstract][Full Text] [Related]
10. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
Douam F; Bobay LM; Maurin G; Fresquet J; Calland N; Maisse C; Durand T; Cosset FL; Féray C; Lavillette D
J Virol; 2016 Jan; 90(2):992-1008. PubMed ID: 26537674
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus entry: role of host and viral factors.
Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S
Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus entry into the hepatocyte.
Belouzard S; Cocquerel L; Dubuisson J
Cent Eur J Biol; 2011; 6(6):933-945. PubMed ID: 32215118
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
[TBL] [Abstract][Full Text] [Related]
15. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
Bukh J
J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
[TBL] [Abstract][Full Text] [Related]
16. Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.
Dao Thi VL; Dreux M; Cosset FL
Expert Rev Mol Med; 2011 Apr; 13():e13. PubMed ID: 21489334
[TBL] [Abstract][Full Text] [Related]
17. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
J Virol; 2018 May; 92(10):. PubMed ID: 29491159
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.
Burlone ME; Budkowska A
J Gen Virol; 2009 May; 90(Pt 5):1055-1070. PubMed ID: 19264629
[TBL] [Abstract][Full Text] [Related]
19. Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a
Tong Y; Chi X; Yang W; Zhong J
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100619
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
